Hosted by ISSX, Frontage's own Dr John Kapeghian discusses the "Cost Effective and Efficient Progression of Lead Drug Candidates to First in Human Studies in the Two Largest Economies in the World: USA and China."

Programs that need to include women in their FIH (first in human) studies will find that successful enrollment of women is achievable; however, it requires a concerted effort, with the correct strategies and proper support. In this paper, we explore the challenges in recruiting women for FIH studies and present a set of practices that have proven successful in improving the recruitment rates of women for these studies.

To ensure good data yield, there are challenges encountered during NGS operations, especially with poor quality RNA or DNA material, which is a common scenario for clinical samples. In this poster, we showcase three key tricks during the NGS operations to generate consistent data with high quality.